How we got here by McLean, I, McMillan, A

The response of a multi-directional composite laminate to through-thickness loading by Tagarielli, V, Minisgallo, G, McMillan, A, Petrinic, N

Changing behavior – ensuring hand hygiene is an institutional priority by Bradford J, Brett J, Bull A, Kennedy B, Borrell S, McMillan A, Richards M

Scoring system to facilitate diagnosis of Gaucher disease by Mehta, A, Rivero Arias, O, Abdelwahab, M, Campbell, S, McMillan, A, Rolfe, MJ, Bright, JR, Kuter, DJ

Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study by Fielding, A, Richards, S, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Rowe, J, Tallman, MS, Goldstone, A

A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PRE... by McMillan, A, Bratton, D, Faria, R, Laskawiec-Szkonter, M, Griffin, S, Davies, R, Nunn, A, Stradling, J, Riha, R, Morrell, M

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): A 12-month, multicentre, randomised trial by McMillan, A, Bratton, D, Faria, R, Laskawiec-Szkonter, M, Griffin, S, Davies, R, Nunn, A, Stradling, J, Stradling, JR, Riha, R, Morrell, M

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial by Fielding, A, Buck, G, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Tallman, MS, Rowe, J, Goldstone, A

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. by Fielding, A, Richards, S, Chopra, R, Lazarus, H, Litzow, MR, Buck, G, Durrant, I, Luger, S, Marks, D, Franklin, I, McMillan, A, Tallman, MS, Rowe, J, Goldstone, A

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results... by Lrrzow, MR, Buck, G, Dewald, G, Fielding, A, Ketterling, R, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results... by Lrrzow, MR, Buck, G, Dewald, G, Fielding, A, Ketterling, R, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results... by Lrrzow, MR, Buck, G, Dewald, G, Fielding, A, Ketterling, R, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. by Fielding, A, Rowe, J, Buck, G, Foroni, L, Gerrard, G, Litzow, MR, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Patel, B, Paietta, E, Tallman, MS, Goldstone, A

Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP by Eyre, T, Martinez-Calle, N, Hildyard, C, Eyre, D, Plaschkes, H, Griffith, J, Wolf, J, Fields, P, Gunawan, A, Oliver, R, Booth, S, McMillan, A, Fox, C, Bishton, M, Collins, G, Hatton, C